| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
OKYO sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.87M | $15.77M | - | |
| CFO | 544.8K | $1.01M | - | |
| Dir | 135.5K | $250.7K | - | |
| Other | 112.4K | $157.4K | - | |
| Dir | 35.2K | $52.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | Brancaccio John P | Director | Buy | 16,670 | $1.50 | $25,005.00 | New | -15.1% | -48.2% | |
| May 19, 2022 | Cerrone Gabriele M | Non-executive Chairman | Buy | 37,500 | $4.00 | $150,000.00 | +150.0% | -32.1% | -53.2% | |
| May 19, 2022 | Jacob Gary S | Chief Executive Officer | Buy | 12,500 | $4.00 | $50,000.00 | New | -32.1% | -53.2% | |
| May 19, 2022 | Cerrone Gabriele M | Executive Chairman | Buy | 5,800,000 | $0.08 | $440,800.00 | +1.1% | -32.1% | -53.2% | |
| May 17, 2022 | Cerrone Gabriele M | Non-executive Chairman | Buy | 1,625,000 | $0.06 | $96,687.50 | +0.3% | -41.4% | -51.9% |